Suspected Pulmonary embolus Ambulatory Pathway. Document Title. Date Issued/Approved: Date Valid From: 11/11/17. Date Valid To: 11/05/18

Similar documents
28 th September Author Jeremy Gilbert Bariatric Nurse Specialist

Clinical Guideline for Intravenous Opioids for Adults in Recovery Areas The Recovery Protocol

CLINICAL GUIDELINE FOR MANAGEMENT OF NEUTROPENIC SEPSIS IN ADULT CANCER PATIENTS (this guideline excludes haematology patients)

CLINICAL GUIDELINE FOR THE ADMINISTRATION OF NEBULISED PENTAMIDINE Summary. 1.

Blood Glucose and Hyperglycaemia Management in Hospital for Adults with Diabetes Clinical Guideline V2.0. March 2018

Start. What is the serum phosphate concentration? Moderate Hypophosphataemia mmol/l. Replace using oral. phosphate. (See section 3.

CLINICAL GUIDELINE FOR THE MANAGEMENT OF HYPOKALAEMIA

SALBUTAMOL INHALER PATIENT GROUP DIRECTION CHILD HEALTH 1. Aim/Purpose of this Guideline

MANAGEMENT OF THE BLADDER IN THE POSTOPERATIVE PERIOD FOLLOWING UNCOMPLICATED GYNAECOLOGICAL SURGERY CLINICAL GUIDELINES

CLINICAL GUIDELINE FOR INTRAVENOUS FLUID THERAPY FOR ADULTS IN HOSPITAL 1. Aim/Purpose of this Guideline

School Hearing Screening Policy

PE Pathway. The charts are listed as follows:

CLINICAL GUIDELINE FOR THE ADMINISTRATION OF MESNA WITH IFOSFAMIDE AND CYCLOPHOSPHAMIDE Summary.

HYPOSPADIAS NEONATAL CLINICAL GUIDELINE. 1. Aim/Purpose of this Guideline. 2. The Guidance

CLINICAL GUIDELINE FOR THE MANAGEMENT OF BARRETT S OESOPHAGUS Summary.

CLINICAL GUIDELINE FOR MANAGEMENT OF GALLSTONES PATHOLOGY IN ADULTS

DIAGNOSIS AND MANAGEMENT OF PYLORIC STENOSIS IN CHILDREN CLINICAL GUIDELINE V3.0

Clinical guideline for the introduction of Sacubitril Valsartan in primary and secondary care in Cornwall

CLINICAL GUIDELINE FOR THE MANAGEMENT OF ANAPHYLAXIS IN INFANTS AND CHILDREN UNDER SIXTEEN YEARS OF AGE V3.0

PRESEPTAL AND ORBITAL CELLULITIS IN CHILDREN- CLINICAL GUIDELINE V3.0

1.1. This guideline applies to medical, nursing and pharmacy staff in the safe and appropriate prescription and administration of acamprosate.

CLINICAL GUIDELINE FOR THE USE OF PHENYTOIN IN EPILEPSY

SHARED CARE GUIDELINE FOR BUCCAL MIDAZOLAM FOR THE TREATMENT OF PROLONGED SEIZURES IN CHILDREN

METABOLIC BONE DISEASE OF PREMATURITY NEONATAL CLINICAL GUIDELINE V3.0

CLINICAL GUIDELINE FOR MANAGEMENT OF ACUTE CHOLECYSTITIS IN ADULTS

Captopril and Enalapril (Ace Inhibitor) Therapy Clinical Guideline V1.0

GESTATIONAL DIABETES MELLITUS AND SUBSEQUENT MANAGEMENT OF CONFIRMED GESTATIONAL DIABETES MELLITUS (GDM) AND SELECTIVE SCREENING - CLINICAL GUIDELINE

Pulmonary Embolism Pathway

SHARED CARE GUIDELINE FOR RIFAXIMIN FOR PREVENTING EPISODES OF OVERT HEPATIC ENCEPHALOPATHY IN ADULT PATIENTS 1. Aim/Purpose of this Guideline

Fasting for Adults (including Young Adults Age 16+ years) who require Anaesthesia or Intravenous Sedation Clinical Guideline V5.0

CLINICAL PROCEDURE FOR THE SAFE REMOVAL OF FEMORAL ARTERIAL SHEATHS USING A DIGITAL APPROACH 1. Aim/Purpose of this Guideline

CLINICAL GUIDELINE FOR USE OF A PATIENT CONTROLLED ANALGESIA OR INTRAVENOUS OPIATE INFUSION IN CHILD HEALTH. 1. Aim/Purpose of this Guideline

Suspected Deep Vein Thrombosis (DVT) Assessment

Patient Controlled Analgesia/Intravenous Opiate Infusion in Child Health Clinical Guideline V4.0 October 2018

SHARED CARE GUIDELINE FOR MODAFINIL 1. Aim/Purpose of this Guideline. 2. The Guidance

MANAGEMENT OF NEONATAL HYPOTENSION CLINICAL GUIDELINE

CLINICAL GUIDELINE FOR THE MANAGEMENT OF HYPONATRAEMIA Summary. Start. End. Key: Na + below normal range ( mmol/L) Symptomatic?

CLINICAL GUIDELINE FOR AN EPIDURAL INFUSION IN CHILD HEALTH 1. Aim/Purpose of this Guideline

CLINICAL GUIDELINE FOR THE MANAGEMENT OF HIGH BLOOD GLUCOSE LEVELS AND SICK DAYS FOR INSULIN PUMP USERS UNDER THE PAEDIATRIC DIABETES SERVICE. V4.

1.0 PATIENT CARE Including Physical Healthcare

A Care Pathway exists for the management of neutropenic fever. Copies of the care pathway document are available in EAU, A&E, Deanesly and CHU.

Procedure for Subcutaneous Injection of Insulin or GLP1 Analogue in Adults Using a Pen Device V2.0

CLINICAL GUIDELINE FOR THE MANAGEMENT OF CONVULSIVE STATUS EPILEPTICUS IN CHILDHOOD V3.0

Trust Guideline for the Management of: Condition or Procedure in Adults and / or Children

The Management of Children and Young People with Newly Presenting Diabetes Clinical Guideline V5.0 December 2018

SHARED CARE GUIDELINE FOR TREATMENT OF DEMENTIA 1. Aim/Purpose of this Guideline

Falls The Assessment, Prevention and Management of Patient Falls (Adult Services) 1.34

CLINICAL GUIDELINE FOR NEONATAL BCG VACCINATION V3.0

PE service. 65 years old lady. What would you do next? Risk stratification. What would you do next? Regional College Lecture PE Management

Management of Acute Pulmonary Embolism. Judith Hurdman Consultant Respiratory Physician

Melatonin shared care guideline. Document Title. Corporate: Clinical. Type of document. Brief summary of contents

Is it safe to manage pulmonary embolism in Primary Care? Roopen Arya King s College Hospital

Clinical Guideline for the Management of Pot Operative Atrial Fibrillation

Hypoglycaemia in Adults with Diabetes Clinical Guideline V5.0. March 2018

CLINICAL GUIDELINE FOR THE EVALUATION OF A CHILD PRESENTING WITH FEVER AND SEIZURE V3.0

Prevention and Treatment of Mucositis in Children and Young People with Cancer Clinical Guideline V3.1 December 2018

Osteoblasts (cells which form new bone) Osteoclasts (cells which break down old bone)

Protocol for the Management of Neutropenic Sepsis in Adult Patients P

CLINICAL GUIDELINE FOR THE MANAGEMENT OF VIRAL LARYNGO-TRACHEOBRONCHITIS (CROUP) V3.0

Please inform the Diabetes Nurse Specialist that this patient has been admitted within 24hrs of admission.

Pathology Service User Guide Haematology

DOAC and NOAC are terms for a novel class of directly acting oral anticoagulant drugs including Rivaroxaban, Apixaban, Edoxaban, and Dabigatran.

DIABETES IN PREGNANCY, TYPE 1 AND TYPE 2 DIABETES MELLITUS (DM), CLINICAL GUIDELINE FOR MIDWIVES V1.4

MUCOSITIS IN CHILDREN AND YOUNG PEOPLE WITH CANCER- CLINICAL GUIDELINE FOR PREVENTION AND TREATMENT V3.0

SHARED CARE GUIDELINE FOR MYCOPHENOLATE MOFETIL FOR RHEUMATOLOGY INDICATIONS 1. Aim/Purpose of this Guideline

Pelvic Inflammatory Disease Clinical Guideline V1.0 February 2019

Suspected Deep Vein Thrombosis (DVT) Pathway for Non Pregnant patients Updated November 2016, with new D-dimer reference range

SHARED CARE GUIDELINE FOR CICLOSPORIN IN DERMATOLOGY. 1. Aim/Purpose of this Guideline. 2. The Guidance

Development of an RANP role, Acute Medicine. Emily Bury RANP, Acute Medicine

Clozapine intramuscular (IM) Guideline, inpatients only

MANAGEMENT OF DIABETES MELLITUS (DM) IN PREGNANCY TYPE 1, TYPE 2 AND GESTATIONAL DIABETES (GDM),CLINICAL GUIDELINE. V1.0

CLINICAL GUIDELINE FOR THE MANAGEMENT OF INPATIENTS WITH PARKINSON S DISEASE

FRACTURED NECK OF FEMUR CLINICAL PATHWAY

PREOPERATIVE ANAEMIA PATHWAY

Treatment of deep vein thrombosis and pulmonary embolism with low molecular weight heparin

PREOPERATIVE ANAEMIA PATHWAY

Adult Chest Wall Injury Pathway V2.0 May 2018

Policy Register No: Status: Public. Contributes to Care Quality Commission Outcome 4

NUH Emergency Department. Guideline for Diagnosis & Treatment of PE (Massive and Non-Massive) in Adults only

NES Asthma Hospital Medication Care Plan 7

SHARED CARE GUIDELINE FOR LITHIUM. 1. Aim/Purpose of this Guideline. 2. The Guidance

Spirometry Clinical Guideline V2.0. May 2018

NHS HIGHLAND. Significant Event Report

Thrombosis Prevention and Anticoagulation Policy

Aneurin Bevan University Health Board Sickle Cell Anaemia and Haemoglobinopathy Screening and Management in Pregnancy Guidelines

Deep vein thrombosis (DVT) and pulmonary embolism (PE) advice for ophthalmic surgery patients

Initiation of Clozapine Treatment Community Patients

Ambulatory Emergency Care Pathways. Painless Obstructive Jaundice

Venous Thromboembolism (VTE) Prevention and Treatment of VTE in Patients Admitted to Hospital

Clinical Guideline for the management of paediatric patients with Diabetes Type 1 & 2 requiring Surgery or General Anaesthetic. V4

Nursing Management Pre /Post Thrombolysis in Stroke

Managing Exacerbations of COPD (Version 3.0)

Reducing the risk of venous thrombo-embolism (VTE) in hospital and after discharge

Emergency Department Guidelines COLLAPSE? CAUSE / SYNCOPE. Version x (x 201x) Review date: x 2014 Page 1 of 5

Datix Ref:

*Abuelmagd Abdalla Department of General Internal Medicine, University College Hospital Galway, Galway, Ireland

URN: Family name: Given name(s): Address: Initial Signature Print Name Role

Admission of a Child/Young Person with Cystic Fibrosis Clinical Guideline V3.0 May 2018

HHS. Hyperglycaemic Hyperosmolar State Care Pathway 1 Presenta8on to 6 hours. Page 1 of 2 AFFIX PATIENT LABEL ! INFORM DIABETES TEAM OF ADMISSION!

Transcription:

POLICY UNDER REVIEW Please note that this policy is under review. It does, however, remain current Trust policy subject to any recent legislative changes, national policy instruction (NHS or Department of Health), or Trust Board decision. For guidance, please contact the Author/Owner. Document Title Suspected Pulmonary embolus Ambulatory Pathway Date Issued/Approved: Date Valid From: 11/11/17 Date Valid To: 11/05/18 Directorate / Department responsible (author/owner): Contact details: 01872 253827 Andrew McSorley, Thrombosis Nurse Specialist Brief summary of contents Suggested Keywords: Target Audience Executive Director responsible for Policy: Date revised: This document replaces (exact title of previous version): Approval route (names of committees)/consultation: Divisional Manager confirming approval processes Name and Post Title of additional signatories Signature of Executive Director giving approval Publication Location (refer to Policy on Policies Approvals and Ratification): Document Library Folder/Sub Folder Links to key external standards Related Documents: Training Need Identified? Suspected Pulmonary embolus Ambulatory Pathway RCHT PCH CFT KCCG Medical Director Under review Vicky Peverelle {Original Copy Signed} Internet & Intranet Intranet Only Clinical / Anticoagulation and Thrombosis Page 1 of 2

This document is only valid on the day of printing Controlled Document This document has been created following the Royal Cornwall Hospitals NHS Trust Policy on Document Production. It should not be altered in any way without the express permission of the author or their Line Manager. Page 2 of 2

15 Minutes Arrival Appendix 1. Suspected Pulmonary Embolus Ambulatory - Pathway Click here for the Suspected Pulmonary Embolus Ambulatory Pathway guidance Key: General Notes ED/MAU/SRU/Acute GP/Amb-Care Start GP/SWASFT In-patient wards Symptoms suggestive of a Pulmonary Embolus Senior first assessment if possible Clinically assess patient and take a full history Any indicators of clinical instability including: Altered level of consciousness. Systolic BP of less than 100 mmhg. Heart rate of more than 110 beats per minute. Respiratory rate of more than 30 breaths per minute. Oxygen saturation of less than 94%. No - commence ambulatory pathway Perform a Wells Score Chest Xray, ECG, Bloods including FBC, UE, LFT, CRP, D- Dimer, clotting Yes senior clinical review Follow ambulatory pathway to expedite investigation if senior assessment indicates this is clinically safe Consider admission and initiate urgent management <4 Wells Score 4 Wells score 4 Do not perform D-Dimer. CTPA indicated. 1 Suspected Pulmonary Embolus Ambulatory - Pathway Page 1 of 4 2

4 hours 2 hours 1 2 Negative Consider alternative diagnosis D-Dimer Positive Request CTPA. If it is not possible to perform a CTPA on the same day then use clinical assessment, ECG and PESI score to ensure patient is suitable to go home after appropriate dose of anticoagulation. Consider community management Consider transfer to ambulatory care unit if patient in ED Positive for PE Consider whether PE was provoked or unprovoked. Anticoagulate as appropriate CTPA Negative for PE Consider alternative diagnosis including DVT Request troponin and combine with ECG findings and PESI score to assess whether patient is safe to be managed in the community Discharge to GP care if clinically stable End Suspected Pulmonary Embolus Ambulatory Pathway Page 2 of 4

Wells Probability Scoring Clinical Features Score Signs of DVT (swelling and tenderness) 3 PE most Likely diagnosis 3 HR > 100 1.5 Previous PE or DVT 1.5 Surgery or Immobilisation 1.5 Cancer diagnosis, recently treated 1 Haemoptysis 1 Total Score <4 (Low Probability) D-Dimer Negative No need to give LMWH prior to investigation <4 D-Dimer Positive Needs LMWH if delayed investigation >4 High Probability LMWH if investigation Delay PES1 Predictor Table Independent Predictors of 30 Day Mortality and points assigned Predictor Points Age per year Age in years Male Sex +10 Cancer +30 Heart Failure +10 Chronic Lung Disease +10 Pulse >110 +20 Systolic BP <100 +30 RR >30 +20 Temp <36 +20 Altered Mental State +60 SATS <90% +20 Total Class 1 Very Low Risk 66-85 Class 2 Low Risk 86-105 Class 3 Intermediate Risk 106-125 Class 4 High Risk >125 Suspected Pulmonary Embolus Ambulatory Pathway Page 3 of 4

Notes Out of Hours If a community GP or an out of hours GP or ED staff suspect a PE, in a stable patient, when the Acute GP service is closed, they can perform an ECG, treat with appropriate anticoagulation and book the patient into the Acute GP Clinic by phoning the Serco call handlers on 01872 226704. The Acute GP service is open 8.30am 7pm weekdays and 10am 5pm weekends Please do not give the patient an appointment or ask the patient to arrive at the Acute GP service the following morning; the Acute GP will contact the patient by phone before 10.30 am the following morning, 7 days a week. The patient should be given the phone number for the Acute GP service 01872 253566 with instructions to ring if they have not been contacted by 10.30am the following morning. Suspected Pulmonary Embolus Ambulatory Pathway Page 4 of 4